Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Everything Worth Reading.
Cataclysm and Conscience Collide in William Ferraiolo’s Interesting New Novel, The Pope of Atlantis
EIN Presswire
·
June 18, 2025
LODI, CA, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- Author and philosopher William Ferraiolo has released his latest work, The Pope of Atlantis. It is a compelling post-apocalyptic novel that confronts the collapse of civilization...
Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway
GlobeNewswire, Inc.
·
June 18, 2025
- New data show clinical safety and early efficacy of SANA, a first-in-class compound that targets creatine-dependent thermogenesis MONTEVIDEO, Uruguay, June 18, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma, a clinical-stage biotechnology company...
Pattern To Test Novel AI-Discovered Molecular De Novo Drug for Treatment of Multiple Hard-to-Treat Cancers
GlobeNewswire, Inc.
·
June 18, 2025
Working with data from the Fred Hutch Cancer Center, and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Pattern identified a novel drug target that is not actively expressed in any adult tissue, but is expressed in a subset...
Synfini Inc. and O2nix Bio Announce Strategic Collaboration to Develop Novel Cancer Therapeutics Targeting FTSJ1
GlobeNewswire, Inc.
·
June 18, 2025
MENLO PARK, Calif. and CAMBRIDGE, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Synfini Inc., a leader in AI-driven drug discovery, and O2nix Bio, a pioneering biotech company advancing prooxidant therapies, today announced a strategic collaboration to...
Author Gary Kidney Discusses WWII Spy Thriller The Eagle Scout Picture on BrightWord Books Podcast
EIN Presswire
·
June 17, 2025
NEW YORK, NY, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- Acclaimed author Gary Kidney made a captivating appearance on The BrightWord Books Podcast, offering listeners an intimate, behind-the-scenes look at his latest historical...
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
GlobeNewswire, Inc.
·
June 17, 2025
PALM BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global diabetic retinopathy market has shown a consistent growth in recent years and is expected to continue for the coming several years. According to a...
'Simone LaFray and the Bishop of Mumbai' Welcomes Readers Back to a World of Spies, Sweets, and Secrets Gone Global
EIN Presswire
·
June 17, 2025
written by S.P. O’Farrell; on sale June 17, 2025 RICHMOND, VA, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- Brandylane Publishers, Inc. of Richmond, Virginia, is excited to announce the release of a new spy novel for middle-grade readers,...
New Fantasy Release Spins A Dazzling Tale of Magic, Memories, and Misadventures With Grandmother-Grandson Duo
GlobeNewswire, Inc.
·
June 19, 2025
Charleston, SC, June 19, 2025 (GLOBE NEWSWIRE) -- Do you believe in magic? You will after reading WHOLE INTO ONE. Ray Taylor and his spirited 90-year-old grandmother Jean embark on an unexpected journey to search for the magic that once made their...
'L. Ron Hubbard Presents Writers of the Future Volume 41' Wins Gold at 8th Annual American Fiction Awards
EIN Presswire
·
June 19, 2025
American Fiction Awards Gold Medal Presented to “L. Ron Hubbard Presents Writers of the Future Volume 41” Anthology. HOLLYWOOD, CA, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- “L. Ron Hubbard Presents Writers of the Future Volume 41,”...
Predictive Intervention: Podcast Introduces Novel Approach to Employee Health Management
GlobeNewswire, Inc.
·
June 17, 2025
MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- Mediterranean Wellness, in collaboration with Health Cost & Risk Management (HCRM), introduces a new process to redefine what it means to proactively manage employee health and healthcare costs. In a new...
Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease
Business Wire
·
June 17, 2025
Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatric diseases, today announced the publication of preclinical data in Nature Communications demonstrating that its lead drug...
Historical Drama Meets Gritty Suspense in Call Me Charlie, the New Novel by Lisa Lynn
EIN Presswire
·
June 16, 2025
JOSHUA, TX, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- In Call Me Charlie, author Lisa Lynn delivers a riveting blend of historical fiction, mystery, and feminist grit. Set in late 19th-century New York, the novel follows Charlotte...
Psychological Thriller The Steel Van Man Debuts as Audiobook July 1st
EIN Presswire
·
June 19, 2025
Narrated by J.J. Hosenfeld, this haunting thriller dives into the mind of a killer. SWAMPSCOTT, MA, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- Acclaimed author of psychological thrillers Jason Stadtlander announces the gripping new...
JAMES HILLMAN OFFERS NOVEL VIEWPOINTS ON THE MUCH-DEBATED SUBJECT OF SCIENCE VS. RELIGION
EIN Presswire
·
June 16, 2025
Veteran soldier and author James Hillman explores the emotional foundations of the science and faith debate with a sense of authentic curiosity YORBA LINDA, CA, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- In “Religion & Science: Thoughts...
Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032
GlobeNewswire, Inc.
·
June 16, 2025
FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that the...
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
GlobeNewswire, Inc.
·
June 16, 2025
- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated...
Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year
GlobeNewswire, Inc.
·
June 16, 2025
BOSTON and LONDON, June 16, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the IND to initiate a Phase 1...
Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway
GlobeNewswire, Inc.
·
June 16, 2025
- New data show clinical safety and early efficacy of SANA, a first-in-class compound that targets creatine-dependent thermogenesis MONTEVIDEO, Uruguay, June 16, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma, a clinical-stage biotechnology company...
AVEROA receives European marketing authorization for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)
GlobeNewswire, Inc.
·
June 16, 2025
XOANACYL is an oral therapy designed to address critical challenges in CKD, including Iron deficiency and hyperphosphatemia Averoa submitted XOANACYL for UK approval via MHRA’s International Recognition Procedure AVEROA actively seeking strategic...
Author and Adjunct Professor A. Keith Carreiro Recently Featured on Close Up Radio
EIN Presswire
·
June 13, 2025
SWANSEA, MA, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- A. Keith Carreiro, a distinguished adjunct professor at Bridgewater State and author, proudly announces his newest endeavor, “The Immortality Wars,” an expansive four-book series,...